Updated Jul 16, 2026
GOLDEN ARTHUR F has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $93K.

| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-03 | TTRX | Turn Therapeutics Inc. | G — Bona-fide gift | 300.0K | $0.00 | |
| 2025-11-26 | TTRX | Turn Therapeutics Inc. | P — Open-market purchase | 9.9K | $3.44 | $34K |
| 2025-11-24 | TTRX | Turn Therapeutics Inc. | P — Open-market purchase | 20.5K | $2.87 | $59K |
| 2025-10-08 | TTRX | Turn Therapeutics Inc. | A — Grant or award | 10.0K | $0.00 |
GOLDEN ARTHUR F is a corporate insider — currently tracked as Director of Turn Therapeutics Inc. (TTRX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($93K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GOLDEN ARTHUR F profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.